22, May 2024
Foam Swab Manufacturer Super Brush LLC Will Exhibit Their Advanced Technology Foam Swabs at APIC
Springfield, MA, May 22, 2024 –Super Brush LLC will exhibit their USA-made foam swab products at Booth #1735 at APIC 2024, June 3-5 in San Antonio, Texas. The Annual Conference of the Association for Professionals in Infection Control and Epidemiology, Inc, is the leading professional association for infection preventionists with more than 15,000 members, including nurses, physicians, public health professionals, epidemiologists, microbiologists, and medical technologists.
Super Brush LLC develops cleaning tools for reusable medical equipment, as well as for applying topical antiseptics and skin protectants.
“Our foam swabs are lint-free, durable and bristle-free and help reduce the potential for bacterial contamination in the healthcare environment” said Diane Henry, Director of Sales for Super Brush LLC. “Especially important to those working in infection prevention, Super Brush’s foam swabs are engineered with no adhesives so that they will not contaminate fluid being applied. Each swab is designed with durable, lint-free foam to ensure that no material will be left behind.”
Stop by and see them at APIC booth #1735 and tell them about your needs for infection control.
- 0
- By Rabindra
22, May 2024
Exploring Japan’s Healthcare Landscape, Opportunities, and Challenges at MEDICAL JAPAN TOKYO
Tokyo, Japan, May 22, 2024 –MEDICAL JAPAN 2024 is set to return from October 9 to 11 at Makuhari Messe, Japan, presenting an exclusive platform tailored for professionals spanning the medical, elderly care, pharmacy, and healthcare sectors while providing exhibitors and visitors access to the Japanese and Asian markets to expand their business footprint.
As a premier medical trade show organized by RX Japan Ltd., it serves as the optimal gateway for healthcare stakeholders looking to forge valuable connections and explore new opportunities in the region.
According to the Business Research Company, the global healthcare market is projected to reach $9,816.85 billion by 2027, with a compound annual growth rate (CAGR) of 5.3%. In the Asia-Pacific region, a CAGR exceeding 4% between 2022 and 2027 is anticipated due to rising demand for consumer health products. The adoption of advanced technology and robotics improves patient care and operational efficiency, with Health Tech solutions playing a vital role in addressing the needs of Japan’s aging population.
While Japan’s healthcare sector offers opportunities, breaking into the market also presents challenges, like Japan’s complex regulatory landscape, fiercely competitive market, and strict compliance to product safety, reliability, and efficacy.
Considering opportunities and challenges, MEDICAL JAPAN TOKYO emerges as a beacon for healthcare exhibitors. This premier exhibition is an invaluable platform for companies to showcase products and services to a targeted audience of professionals, potential clients, and key decision-makers across medical, elderly care, pharmacy, and healthcare sectors. Exhibiting at the event signals credibility and commitment to the market, showing stakeholders dedication to serving healthcare industry needs.
One of the standout features of MEDICAL JAPAN TOKYO is its emphasis on face-to-face interactions, fostering connections, collaborations, and partnerships, where exhibitors gather valuable contacts, explore sales leads, and nurture forged relationships further.
Moreover, the exhibition provides a conducive environment for firsthand market research. Engaging with attendees allows businesses to gain insights into market trends, customer preferences, and competitor offerings, empowering them to fine-tune market entry strategies.
This October 2024, MEDICAL JAPAN TOKYO is poised to welcome a projected 18,000 visitors. The event boasts six dynamic sub-shows: Hospital Expo, Clinics Expo, Elderly Care & Welfare Expo, Pharmacy Solutions Expo, Infection Prevention Expo, and Japan Wellness & Health Expo. Adding to the excitement, this edition will introduce seven new fairs nestled within these sub-shows, catering to various facets of healthcare: Aesthetic Medicine Fair, Health Foods & Supplements Fair, Dental/Oral Care Fair, Nursing Fair, Sleep Fair, Work Style Reform for Doctors Fair, and Patient Acquisition Marketing Fair.
This diverse array of sub-shows and new fairs empowers exhibitors to strategically align their products with the most relevant expo, maximizing visibility and engagement. Similarly, visitors can swiftly discover tailored solutions within this comprehensive framework.
MEDICAL JAPAN TOKYO is still open for exhibitors, including importers, distributors, and proprietors of hospitals, clinics, and elderly care facilities, to showcase their innovative products and solutions. Renowned as a premier event, it offers a seamless platform for connecting with key players in both Japanese and Asian markets.
22, May 2024
JV Ventures launches The Medical Centre (TMC), a bespoke healthcare-dedicated infrastructure platform
Hyderabad,22nd May 2024: JV Ventures, an investment management firm with a focus on value-added infrastructure, today announced the launch of The Medical Centre (TMC). TMC is a holistic real estate solution that will create the best-in-class healthcare facility by bringing together convenient end-to-end medical services and integrated wellness under one roof. The first TMC centre with be operational at HITECH City in Hyderabad.
JV Ventures has already established two path-breaking, differentiated platforms in education and life sciences with a combined portfolio of USD 500 million. While the flagship centre opens in the city in another six months, TMC will endeavour to open 75 centres across key cities including Bengaluru and Pune in the next 5 years with a target investment of USD 600 million.
Raja Jain was appointed as the CEO of TMC. Raja comes with over 20 years of experience including over a decade in the development and leasing of commercial and retail assets. His last assignment as Vice President of mall Management and Centre Head for Jio World Drive, Mumbai was a category creator in its own right. Before that, Raja served in senior management positions at Makers Group, CBRE, and Inox Leisure Limited.
TMC centres are ideally located near residential neighbourhoods offering patients easy access to healthcare services with best-in-class experience. These centres are multi-tenanted facilities that bring speciality clinics, physicians, diagnostics and pharmacies under one roof.
At the same time, they provide an opportunity for doctors and clinics to lease purpose-built medical facilities that save upfront investments in infrastructure. Each centre is designed to be code-compliant and with amenities like stretcher lifts, ample parking, wheelchair access, and professionally managed facilities. TMC platform also undertakes built-to-suit for hospital chains, offering a unique proposition to increase their footprint in new locations in alignment with their asset-light approach to expansion.
Beyond real estate, TMC is also complemented with two offerings – The Specialist and Prescriptions – that help doctors become entrepreneurs. The Specialist offers a medical co-working space for doctors with flexible leasing models. These fully furnished, experiential spaces within medical centres are complemented with trained support staff and facility management services that minimize administrative burdens and costs for doctors. In parallel, patients get hassle-free access to multi-specialists saving time on medical appointments. Through its digital community platform, The Specialist also gives member doctors an avenue to create awareness on specific topics that benefit patients, at large.
Prescriptions is the venture capital arm that provides access to funding for doctors to take up entrepreneurship. Through its pool of funds raised from angel investors, family offices and high net-worth individuals, Prescriptions offers equity-linked investments to young medical professionals looking to establish themselves as independent practitioners.
Elaborating on the concept, Vishal Goel, co-founder of JV Ventures, shared, “India is likely to witness an exponential growth in demand of hospital beds for in-patient services that may grow at a CAGR of 4.8% to reach 3.57 million by 2033. Fuelled by limited public investment, this demand would increase the per capita availability of hospital beds from 1.6 per 1000 in 2023 to 2.4 in 2033. In light of the burgeoning healthcare needs in India, there is a shortage of purpose-built infrastructure and an ecosystem that promotes medical entrepreneurship. We believe the TMC platform, with its multi-pronged approach will be a game-changer that will redefine how healthcare services are provided”.
Jasmeet Singh Chhabra, co-founder, of JV Ventures commented, “The addition of TMC to our portfolio is a testament to our efforts to invest and develop socially relevant infrastructure with community at its core. In addition to that, it warrants our investment partners’ favourable returns given the rising demand for such centres which is expected to double in the next decade.”
“I am excited about the overall impact of our endeavour with this platform”, said Raja Jain, CEO of The Medical Centre. “This is a great opportunity to develop a unique, first-of-its-kind offering in India. Our first centre of about 35,000 sq ft is in HITEC City, a prominent IT and residential hub in Hyderabad and we look forward to expanding our footprint to Bengaluru, Pune, and other major cities.”
The Indian healthcare industry is experiencing a profound transformation, fuelled by a convergence of economic, social, and policy factors. Healthcare expenditure is projected to grow at a compound annual growth rate (CAGR) of 15-17%, reaching an impressive INR 7.67 trillion by fiscal 2025. In 2023, India accounted for over USD 4.6 billion of the total USD 14 billion private equity investments in the healthcare segment in Asia Pacific region.
In light of the momentum gathered by healthcare in India, innovative business models amongst healthcare providers are emerging to bring in operational efficiencies. There has been a shift from in-patient services in hospitals to out-patient services in specialized centres, specifically for cardiac ailments, diabetes, eye-care, and birthing centres: The demands for specialized medical centres for out-patient services is expected to double in the next decade to a real estate value of over USD 1 billion. Moreover, the top 25 Indian cities are estimated to have a demand of about 15 million sq ft of medical centres by 2033, a staggering 10% of the total out-patient demand projected across the country.
22, May 2024
Managing Fear Author Offers Journalists Mental Health Advice

Carnegie, PA, May 22, 2024 — It is challenging to manage one’s mental health with all of the negative news that we hear about on a daily basis. Unfortunately, many journalists and reporters also struggle with their mental health as they report the news.
Reporters and journalists privately struggle with long hours, managing tight deadlines, job uncertainty, endless meetings, and the mental health toll of covering the news.
Stan Popovich has dealt with anxiety for 20+ years and wrote a managing fear book at www.managingfear.com. You can also Google Stan Popovich.
Stan noticed that many journalists struggle, as he worked with them in developing various mental health stories and interviews on Fox, ABC, CBS, and NBC news over the years.
Mr. Popovich suggests the following solutions to some of these common mental health stresses that journalists deal with. Please pass this along to others.
1. Long hours and the pressure to meet deadlines.
Prioritize and do the most important items first. Learn to plan ahead and take breaks. Communicate with others if you have too much on your plate. Getting burned out will only lead to decrease in performance and increased anxieties/depression.
2. Cover stories and topics that can take a mental toll.
Do not ignore any potential mental health symptoms such as increased anxiety and episodes of depression in your life. Join a local mental health support group and talk to a mental health counselor who can provide help with managing your mental health.
3. Job uncertainty and decrease in workplace morale.
Focus on doing the best job that you can and develop friendships with others. Keep your resume current and develop a network of friends in the media industry. Being proactive in your career will increase your chances of having options which will reduce your anxieties.
4. Everyone is demanding.
Communication is key. It’s important to get see things from the other person’s point of view and try to find solutions that work for everyone. Learn to delegate when possible. You can’t please everyone so just do your best and go from there.
5. Are you still struggling?
Get advice from others in your professional and personal network on what you can do. Talking to others can give you ideas and different approaches in dealing with your current job issues. Do not ignore your mental health for your job because it will catch up to you.
If you struggle with depression, stress, and anxiety, it is important that you talk to a mental health counselor right away. You do not have to privately suffer with your mental health struggles.
21, May 2024
Focus Clinic Announces Opening of Comprehensive ADHD and Learning Disabilities Center

Wyoming, MI, May 21, 2024 — Focus Clinic, specializing in ADHD and learning disabilities, is pleased to announce its grand opening. Focus Clinic provides a unique, all-inclusive approach to diagnosing and treating ADHD, cognitive deficiencies, behavioral problems, and learning disabilities, combining advanced medical, developmental, and educational assessments under one roof. The clinic aims to revolutionize care by offering comprehensive evaluations, pharmacogenetics, microbiome assessments, and personalized treatment plans.
Focus Clinic is built on the belief that every child is made on purpose and for a purpose by a loving God. The clinic’s mission is to help children identify and celebrate their gifts, ensuring they do not feel broken or pressured to change through medication. Instead, Focus Clinic aims to make aspects of their lives easier through medical support while helping them understand who they are and build skills to be the best versions of themselves.
“At Focus Clinic, we are dedicated to understanding the full spectrum of factors influencing ADHD and learning disabilities,” said Dr. Randall J. Duthler, Founder and CEO of Entropy Health, PLLC. “Our integrative approach allows us to provide personalized care that addresses not just the symptoms, but the underlying causes, ensuring that each patient receives the most effective treatment.”
Focus Clinic’s services include a detailed history and physical exam, digital diagnostics for attention and cognition, learning disability assessments, and personality testing. The clinic also offers a variety of medical diagnostics, including screening for endocrine disorders, genetic testing, and home sleep studies. Additionally, Focus Clinic provides nutritional and microbiome assessments. Patients benefit from individualized care plans, shared decision-making, and interventions such as prescription medication, digital performance training, and nutritional support.
One of Focus Clinic’s standout features is its use of Quantitative Electroencephalography (qEEG) brain mapping, an FDA-approved tool that measures brainwave activity to identify regions with abnormal patterns. This advanced diagnostic tool helps healthcare professionals develop targeted interventions to rebalance brain activity and improve patient outcomes. The clinic also utilizes QBTech for sustained attention testing and Creyos tools for cognitive testing.
“By offering a wide range of services in one place, we can provide a more holistic and accurate diagnosis. This is particularly important when considering the potential cognitive impacts of COVID,” Dr. Duthler explained. “Our goal is to empower patients and their families with the knowledge and tools they need to achieve better health and educational outcomes.”
Focus Clinic also emphasizes collaboration with primary care providers and offers IEP advocacy to ensure educational plans include beneficial interventions tailored to each child’s unique needs. The clinic’s comprehensive approach includes progress tracking and AI learning programs, providing continuous support for patients’ long-term success.
20, May 2024
iHridAI Launches AI-ML Diagnostic Tool HarmonyCVI for Cardiac MRIs

Bengaluru, 20th May 2024: iHridAI, an upcoming healthcare technology startup focused on developing globally benchmarked and viable technology solutions for healthcare diagnostics, has today launched its flagship product, HarmonyCVI, for detailed and accurate cardiovascular assessments. HarmonyCVI is a comprehensive AI/ML-based rapid diagnostics and insights tool that aids cardiologists and radiologists in enhanced analysis of cardiac MRI scans.
Grounded on robust research, cardiothoracic models and extensive real-world cardiac imaging data, HarmonyCVI leverages deep learning AI/ML capabilities. It inputs the patient’s MRI studies, learns respective metrics, and predicts various parameters, including dynamic contours and segmentation. The software uploads its comprehensive findings from processing and analysis into clinical data reports, which can be monitored and modified on a dashboard.
The technology solution empowers radiologists and cardiologists with accurate and clinically reliable information, facilitating rapid and informed decision-making, typically within a few minutes. HarmonyCVI helps clinicians quickly assess the key parameters for comprehensive diagnosis, thereby aiding in practical assessment and treatments. The integrated platform offers real-time interactive report generation with automated report data analysis in the desired format.
Commenting on the launch, Sai Sangineni, Founder, iHridAI said, “Resonating with the vision to create globally benchmarked AI-based healthcare solutions, we launched HarmonyCVI for the clinical community. The tool is fundamentally designed to enhance the accessibility, accuracy and affordability of real-world cardiac MRI diagnostics. Using these comprehensive and detailed insights, patients with critical cardiac MRIs can be triaged for advanced and accurate review and assessed treatments. The core of our innovation addresses the need for cost effective PAR for the growing cardiac MRI adoption. At iHridAI, we strive forward to align with the new realities of preventive patient care using AI and continue to develop value-based solutions for the larger medical fraternity.”
Dr. Vimal Raj, Clinical Advisor and Co-founder, iHridAi further adds, “The launch of HarmonyCVI reinforces our commitment towards curating an AI-based solution for analyzing cardiac MRI scans rapidly. While the PAR (processing, analyzing and reporting) for ECG, CT, PET and other MRIs is straightforward today, the complex cardiac MRIs need a vendor-agnostic, economically viable, easy-to-deploy solution to drive the adoption and further growth of cardiac MRI usage in advanced heart diagnostics. Harmony CVI is easy to learn, deploy and use. The user interface, speed, precision and diagnostic accuracy will help physicians with early diagnosis, thus improving better clinical outcomes of patients.”
iHridAI is fostering a collaborative approach, leveraging partners and providers for advanced and complementary domain expertise and solution engineering. This includes key radiologists, researchers, and medical imaging/AI experts. HarmonyCVI is the first product launched into this ecosystem, fully-tested and vetted with a critical mass of real-world datasets from various sources. iHridAI is simultaneously working towards developing a single integrated multi-model AI analytics platform which covers ECG, ECHO, CT and MRI.
20, May 2024
WOW Skin Science Shields Bengaluru’s Traffic Warriors from Scorching Summer Sun

India, May 20, 2024: As temperatures soared in Bengaluru this summer, WOW Skin Science joined hands with the Bengaluru Police to address the challenges faced by our frontline heroes combating the scorching sun and dust. According to the Indian Meteorological Department (IMD), Bengaluru experienced one of its hottest summers in recent years, intensifying the need for effective sun protection.
As part of its commitment to supporting frontline workers, WOW Skin Science presented 250 sun protection kits containing their new WOW Sunscreen Gels to Bengaluru’s traffic warriors. These kits provided much-needed protection against harmful UV rays and helped mitigate the risk of skin damage caused by extended sun exposure.
Mr. Manish Chowdhary, Co-Founder of WOW Skin Science, highlighted the significance of this collaboration, stating, “WOW Skin Science is committed to the well-being of those who protect our community. Our partnership with the Bengaluru Police aims to provide essential sun protection to our brave traffic warriors, who face prolonged exposure to harsh sunlight during their duties. We are honoured to contribute to the well-being of our traffic warriors.”
Recognizing the critical role of the Bengaluru Police in maintaining public safety, WOW Skin Science conducted extensive interviews and research to understand the unique challenges faced by the traffic police force during summer months. The findings revealed that prolonged exposure to the sun could lead to health risks and various skin problems, including infections, pigmentation, and dark spots.
Studies indicated that on average, a person could endure only about one hour of peak sunlight without risking sunburn. For officers exposed for longer periods, such as traffic police, effective sun protection was crucial.
With a profound sense of gratitude for our traffic warriors, WOW Skin Science remains committed to fostering lasting partnerships that uplift and empower those who serve our communities with grit and determination.
20, May 2024
Bodycraft Clinic launches groundbreaking skin and hair rejuvenation treatment YouthX in India

India, 20 May 2024:Bodycraft Clinic, a leading name in advanced aesthetic treatments, recently announced the launch of YouthX, a groundbreaking skin and hair rejuvenation treatment. YouthX harnesses the potent capabilities of Bone Marrow cells to revolutionise skin and hair rejuvenation. Bodycraft Clinic is one of the first clinics in India to offer this innovative technology.
YouthX’s formulations trigger cell growth and repair by stimulating collagen synthesis thus fostering firmer, smoother skin while diminishing wrinkles. Moreover, YouthX accelerates tissue repair, minimising blemishes like acne scars and hyperpigmentation for a renewed complexion. For those seeking voluminous hair, YouthX offers a specialised solution targeting dormant follicles, fostering thicker, healthier growth for a fuller mane.
Commenting on the launch, Sahil Gupta, CEO of Bodycraft says, “Bodycraft Clinic is proud to introduce YouthX, a breakthrough solution at the intersection of science and nature. YouthX delivers a transformative client experience, driving superior results in skin and hair rejuvenation. Our commitment is to bring the advanced treatments that are available worldwide, right to our clients.”
YouthX is a clinically tested treatment that is proven to deliver effective results in promoting cellular health. This treatment utilizes tiny vesicles, acting like messengers between cells, that are packed with beneficial molecules. These microscopic packages, millions of times smaller than a human hair, are confirmed to contain a wealth of growth factors and proteins known to enhance cellular regeneration and reduce inflammation.
“In my practice, I always seek innovative, evidence-based approaches to improve patient outcomes. YouthX aligns with this philosophy perfectly. The core therapy utilizes a derivative of bone marrow stem cells, specifically excluding genetic material like DNA and RNA. This approach holds promise for regenerating and repairing skin tissue. Combined with natural rejuvenation techniques, YouthX offers a compelling path to achieving optimal aesthetic results and a renewed sense of well-being for my patients,” said Dr. Mikki Singh, founder and Medical Director of Bodycraft Clinic.
With YouthX, Bodycraft introduces a pioneering duo of treatments tailored to individual needs: YouthX Skin addresses hyperpigmentation, scars and marks, fine lines, and the appearance of pores, while YouthX Hair promotes natural, healthy hair growth – without surgery or hormonal side effects!
The field of aesthetics is constantly evolving, with new technologies emerging that offer minimally invasive and more personalised approaches to achieving desired results. Treatments like YouthX represent a promising area of development, and Bodycraft Clinic is proud to be at the forefront of offering this innovative technology to our clients.
20, May 2024
Citizens Specialty Hospital Hosts India’s First CME on E-CPR in ED, Sets New Milestone in Emergency Medicine

Hyderabad, 20th May 2024: Citizens Specialty Hospital marked a significant milestone by hosting the country’s first Continuing Medical Education (CME) session on CODE E-CPR in the Emergency Department (ED) at its Hyderabad facility. The event witnessed the participation of 60 delegates and 20 faculties, comprising esteemed medical professionals and experts in the field.
CODE E-CPR, an abbreviation for Extracorporeal Cardiopulmonary Resuscitation, is a groundbreaking salvage procedure that involves the emergent initiation of extracorporeal membrane oxygenation (ECMO) on patients who have experienced cardiac arrest, particularly when conventional cardiopulmonary resuscitation (CCPR) has proven ineffective.
Dr Imron Subhan, Executive Chairman of the Society for Emergency Medicine India (SEMI) board, honored the event with his distinguished presence as the Chief Guest. Dr Subhan remarked, “This CME marks a pivotal moment in the landscape of emergency medical care in India. It is the first of its kind dedicated to E-CPR, especially within an ED setup congratulate the citizens ED team lead by Dr Sridhar Maram. Citizens Specialty Hospital’s initiative reflects a commitment to advancing medical knowledge and improving patient outcomes.”
The ceremonial lamp lighting was conducted by esteemed Dr Mir Raza Ali Khan, Dr Sridhar Maram , Dr Sudhir Koganti, Dr Gopal, along with Dr Amarendra Singh, Dr Dr Santosh Kumar Paiaulla, Dr Lakshmi Sasidhar Puvvula, Dr Bharath Kumar Pamulapati signifying the illumination of knowledge and expertise in the field of emergency medicine.
Dr Imron Subhan emphasized the significance of such initiatives, stating, “Incorporating ECPR into emergency medical protocols has the potential to revolutionize resuscitation efforts and save countless lives. It’s encouraging to witness institutions like Citizens Specialty Hospital taking proactive steps in this direction.”
Dr Sridhar Maram ( HOD ER ), Organising Chairman for this CME on CODE E CPR IN ED stated that this is the first CME in India on ECMO CPR especially in ED setting with incorporation of selection criteria of patient and protocol approach in initiation of E CPR which will help all ER Physicians to initiate and resuscitate of a cardiac arrest patient.
Dr Mir Raza Ali Khan, (Director Medical operations and quality) Citizens Specialty Hospital, expressed his enthusiasm for the event, stating, “The introduction of ECPR represents a paradigm shift in our approach to cardiac arrest management. This CME serves as a platform for sharing best practices and fostering collaboration among healthcare professionals.”
Citizens Specialty Hospital remains committed to driving innovation and excellence in healthcare, with a focus on enhancing patient care and outcomes through continuous education and collaboration within the medical community.
18, May 2024
MERIL’s Next-Gen Myval THV Series Marks India’s Triumph in Global Heart Valve Sector

Hyderabad, 18 May 2024: Exciting news from Meril Life Sciences! The LANDMARK trial’s 30 days primary outcomes were presented on 15th May at EuroPCR 2024, Paris, France. LANDMARK was recognized by EuroPCR as one of the top three late breaking trials poised to transform revolutionise current practices in the field of Interventional Cardiology.
The LANDMARK study showed that the performance of Myval THV series in terms of safety and effectiveness was non-inferior to the contemporary THV series (24.7% vs. 27.0%, occurrence of primary composite endpoint which is composite of deaths, stroke, major bleeding, acute kidney injury, major vascular complications, moderate or severe valve regurgitation, and the need for new permanent pacemaker implantation as per the third Valve Academic Research Consortium consensus) with no difference in the itemized components of the primary composite endpoints. The other secondary endpoints including technical success at exit from procedure room, device success at 30 days and early safety at 30 days were comparable in both the groups.
Professor Serruys, Chairman & study director of the LANDMARK trial, said “Myval THV series are novel next-gen THV devices; non-inferior to the Sapien and Evolut THV series. Myval THV series have a unique size matrix incorporating conventional, intermediate and extra-large diameters with increasing diameter steps of 1.5mm that match and fit precisely the multi slice CT scan-defined aortic annulus area of each individual patient, as a result, provides a superior effective orifice area on echocardiography, which may impact on durability and long-term clinical outcomes. Additionally, the Myval Octacor, with its 2 rows of octagonal cells and a minimal foreshortening of 19% during expansion, has unique features not paired by any other contemporary design.”
Myval THV series has a versatile range of sizes offering not only traditional sizes (20 mm, 23 mm, 26 mm, 29 mm) but also intermediate (21.5 mm, 24.5 mm, 27.5 mm) and extra-large sizes (30.5 mm and 32 mm). This tailored sizing matrix allows cardiologists to select the appropriate valve size, thus avoiding excessive over- or under-sizing. In the LANDMARK trial, 48.1% of the patients were implanted with the intermediate size of Myval THV series.
As per the Global Principal Investigator, Prof. Andreas Baumbach, “The Landmark trial showed that the Myval THV series performed as safe and effective as contemporary THV series. It is a valve made for everyday clinical practice and an all-comers population. The special feature of intermediate diameters allows for more accurate sizing, which has the potential to translate into improved long-term outcomes. Our patients will be followed up for 10 years and it will be interesting to see the long-term results in the three treatment arms.”
Mr. Sanjeev Bhatt, Sr. Vice President – Corporate Strategy at Meril said, ” In a successful development in structural heart interventions, the LANDMARK RCT has revealed compelling results for the novel Myval transcatheter heart valve (THV) series, confirming its non-inferiority to other contemporary THV devices. The results of LANDMARK trial are not just a win for us but for the entire medical community and, most importantly, for patients undergoing TAVI. This study not only reinforces the safety and efficacy of the Myval THV series but also highlights its adaptability to challenging anatomical structures,”.